Search Results - "Vilardell, Enric"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Effects of thromboxane synthesis inhibitor triflusal on renal hemodynamics in microalbuminuric diabetic patients by Esmatjes, E, Conget, J I, Gaya, J, Fernandez, M R, Ferrer, J P, Rivera, F, Vilardell, E

    Published in Diabetes care (01-11-1990)
    “…Effects of thromboxane synthesis inhibitor triflusal on renal hemodynamics in microalbuminuric diabetic patients. E Esmatjes , J I Conget , J Gaya , M R…”
    Get full text
    Journal Article
  2. 2

    Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults by Gómez, José Manuel, Espadero, Rosa María, Escobar-Jiménez, Fernando, Hawkins, Federico, Picó, Antonio, Herrera-Pombo, José Luis, Vilardell, Enric, Durán, Alejandra, Mesa, Jordi, Faure, Eduardo, Sanmartí, Anna

    Published in Clinical endocrinology (Oxford) (01-03-2002)
    “…Summary objective To investigate the GH response to glucagon in adult patients with GH deficiency and in controls compared with the GH response to the insulin…”
    Get full text
    Journal Article
  3. 3

    Signals derived from glucose metabolism are required for glucose regulation of pancreatic islet GLUT2 mRNA and protein by FERRER, J, GOMIS, R, ALVAREZ, J. F, CASAMITJANA, R, VILARDELL, E

    Published in Diabetes (New York, N.Y.) (01-09-1993)
    “…Pancreatic islet GLUT2 mRNA is known to be regulated in vitro and in vivo by glucose. We have investigated several potential mechanisms mediating the response…”
    Get full text
    Journal Article
  4. 4

    Genetic analysis of seven Mediterranean families with multiple endocrine neoplasia type 2A by Oriola, J, Hernandez, C, Simo, R, Barcelo, A, Casamitjana, R, Vilardell, E, Rivera-Fillat, F

    Published in Clinical endocrinology (Oxford) (01-02-1996)
    “…Genetic analysis is now essential for the accurate screening of families with multiple endocrine neoplasia type 2 (MEN2). We present the genetic analyses by…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Effects of a short prednisone regime at clinical onset of type 1 diabetes by Goday, A, Pujol-Borrell, R, Fernandez, J, Casamitjana, R, Rios, M, Vilardell, E, Gomis, R

    Published in Diabetes research and clinical practice (01-04-1993)
    “…The effect of corticosteroids on beta cell function and humoral immune response in type 1 diabetes was tested in a 2-month trial conducted on 32 newly…”
    Get more information
    Journal Article
  8. 8

    Microalbuminuria development in short-term IDDM by González-Clemente, J M, Esmatjes, E, Navarro, P, Ercilla, G, Casamitjana, R, Rios, M, Levy, I, Gomis, R, Vilardell, E

    Published in Diabetes research and clinical practice (01-05-1994)
    “…To assess risk factors associated with microalbuminuria development in short-term evolution insulin-dependent diabetes mellitus (IDDM) we undertake a…”
    Get more information
    Journal Article
  9. 9

    Primary localized cutaneous amyloidosis and familial medullary thyroid carcinoma by Ferrer, J P, Halperin, I, Conget, J I, Alsina, M, Martinez-Osaba, M J, Palou, J, Bombi, J A, Vilardell, E

    Published in Clinical endocrinology (Oxford) (01-06-1991)
    “…We have studied a family with an autosomal dominant inheritance of primary localized cutaneous amyloidosis (PLCA) and familial medullary thyroid carcinoma…”
    Get more information
    Journal Article
  10. 10
  11. 11

    HLA antigens in Spanish type 1 diabetic population. Correlations with clinical, biological and autoimmune markers by Goday, A, Motaña, E, Ercilla, G, Fernandez, J, Gomis, R, Vilardell, E

    Published in Acta Diabetologica Latina (01-07-1990)
    “…The HLA haplotype and its relationships with clinical, biological and immunological parameters were analyzed in a group of 87 Spanish type 1 diabetic patients…”
    Get full text
    Journal Article